Back To: Home



October 8 - November 10, 2014

October 18-22, 2014
ASHG - Bostom, Ma

More Events
Name:
Company:
Email:
 
 
 

RNAi collaboration
06-12-2006
by Randall C. Willis  |  Email the author
SHARING OPTIONS:

COLOGNE, Germany—Gene-transfer specialist amaxa and Lafayette, Colo.-based Dharmacon, a division of Fisher Biosciences, recently announced an agreement to co-promote Dharmacon's siRNA libraries with the German company's Nucleofactor technology.
 
The hope is that the combined technologies will further facilitate the application of RNAi-based gene silencing in drug discovery and development by improving the high-throughput transfer of nucleic acids into cells.
 
According to Dr. William Marshall, VP of technology and business development at Fisher Biosciences, the two companies will work closely to provide customers with coordinated technical service, pre-tested protocols, and application models.
 
"We believe Dharmacon provides excellent quality siRNA, and that made the company an obvious choice for partnering," Rainer Christine, CEO of amaxa, added. "By working closely with Dharmacon, we can help researchers accelerate the speed and accuracy of their experiments using siRNA."

Back








CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.